On March 11, 2020, the World Health Organization (WHO) made the assessment that COVID-19 outbreak could be characterized as a pandemic due to the alarming levels of spread and severity. In April 2020, WHO included loss of smell (anosmia) and loss of taste (ageusia) into the official list of common COVID-19 symptoms. The statistics in COVID-19 positive children and adolescents show that loss of smell and taste are common symptoms not only in adults but in pediatric patients as well and may even be the only presentation of the abovementioned infection. The aim of the study is to review the publications subject to the problem of COVID-19 associated anosmia incidence in pediatric patients as well as its pathogenesis, diagnostics, treatment and recovery. The peculiarity of pediatric COVID-19 anosmia is due to children accounting for very low percentage of COVID-19 patients (comparing to one in adults), mostly with milder course of the disease. Awareness of anosmia and its proper diagnostics is crucial in children and adolescents, considering it can be the only manifestation in COVID-19 positive pediatric patients. That is why studying the trustworthy subject resources plays an important part in professional experience exchange for earlier detection of the disease and prevention of its further spread.